Homepage > Company > Media > Pharma News > 2021 > Moderna has renamed its coronavirus vaccine

Moderna has renamed its coronavirus vaccine

The American company Moderna has changed the name of its coronavirus vaccine, it follows from the data of the European Medicines Agency (EMA).

Previously, the name of the drug coincided with the name of the company, but now the vaccine will be called Spikevax. Moderna does not report the reasons for the name change.

In early May, the World Vaccine Congress recognized Moderna as the best vaccine against COVID-19. The shortlist then included the Russian Sputnik V, as well as AstraZeneca, Bharat Biotech, Janssen, Medicago, Novavax, Pfizer / BioNtech and the animal vaccine Zoetis.

The EMA confirmed the safety of the Moderna vaccine in early March. At the end of April, the World Health Organization added this drug to the list of recommended vaccines for emergency use.

June 24, 2021

http://scooptrade.com/

Read also

uniQure Staggers as FDA Questions Data for Huntington’s Gene Therapy Candidate

Agency torpedoes company's plans to submit BLA for gene therapy AMT-130 in Q1 2026.

Kimberly-Clark buys troubled Tylenol-maker Kenvue for $48.7bn

Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for $48.7bn.

Femasys gets FDA OK for final FemBloc trial, secures $12M financing, stock surges

Femasys (FEMY) on Monday said that the FDA approved continuation of the final phase of its FemBloc pivotal trial, sending shares 25% higher in premarket trading.

Praxis announces

Praxis announces accelerated development path for relutrigine in SCN2A and SCN8A DEE patients following positive FDA feedback